1. Home
  2. CUB vs RZLT Comparison

CUB vs RZLT Comparison

Compare CUB & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUB
  • RZLT
  • Stock Information
  • Founded
  • CUB 2024
  • RZLT 2010
  • Country
  • CUB United States
  • RZLT United States
  • Employees
  • CUB N/A
  • RZLT N/A
  • Industry
  • CUB
  • RZLT Biotechnology: Pharmaceutical Preparations
  • Sector
  • CUB
  • RZLT Health Care
  • Exchange
  • CUB NYSE
  • RZLT Nasdaq
  • Market Cap
  • CUB 322.6M
  • RZLT 361.3M
  • IPO Year
  • CUB 2024
  • RZLT N/A
  • Fundamental
  • Price
  • CUB $10.50
  • RZLT $4.10
  • Analyst Decision
  • CUB
  • RZLT Strong Buy
  • Analyst Count
  • CUB 0
  • RZLT 6
  • Target Price
  • CUB N/A
  • RZLT $12.00
  • AVG Volume (30 Days)
  • CUB 130.4K
  • RZLT 716.2K
  • Earning Date
  • CUB 05-13-2025
  • RZLT 05-13-2025
  • Dividend Yield
  • CUB N/A
  • RZLT N/A
  • EPS Growth
  • CUB N/A
  • RZLT N/A
  • EPS
  • CUB 0.34
  • RZLT N/A
  • Revenue
  • CUB N/A
  • RZLT N/A
  • Revenue This Year
  • CUB N/A
  • RZLT $35.39
  • Revenue Next Year
  • CUB N/A
  • RZLT N/A
  • P/E Ratio
  • CUB $31.37
  • RZLT N/A
  • Revenue Growth
  • CUB N/A
  • RZLT N/A
  • 52 Week Low
  • CUB $9.96
  • RZLT $2.22
  • 52 Week High
  • CUB $10.61
  • RZLT $6.19
  • Technical
  • Relative Strength Index (RSI)
  • CUB N/A
  • RZLT 50.40
  • Support Level
  • CUB N/A
  • RZLT $4.10
  • Resistance Level
  • CUB N/A
  • RZLT $4.56
  • Average True Range (ATR)
  • CUB 0.00
  • RZLT 0.25
  • MACD
  • CUB 0.00
  • RZLT -0.05
  • Stochastic Oscillator
  • CUB 0.00
  • RZLT 11.48

About CUB LIONHEART HOLDINGS

Lionheart Holdings is a blank check company.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.

Share on Social Networks: